Free. Simple. Effective. Over 50,000 Cases Processed! |
|
Avandia (Diabetes Medication) - Linked to Heart Failure and Stroke Emerging Class Action Lawsuit
| Avandia (Diabetes Medication) - Linked to Heart Failure and Stroke |
SPREAD THE WORD |
|
|
||
| | 397 | LEAD PLAINTIFF: balthazar Case Filed: 2010-02-03 |
 |
|
Case Summary: Avandia (Rosiglitazone) is a prescription medication used to treat type two diabetes. It works by aiding the body's natural use of insulin, thereby lowering blood sugar. It was originally developed in 1999 and has been used by more than four million diabetes patients. In recent years, Avandia has been linked with dangerous side effetcs including an increase in the risk of heart attack (myocardial infarction). In 2001, the Food and Drug Administration (FDA) asked manufacturer GlaxoSmithKline to stop providing information which minimized the alleged risks associated with Avandia use. The following year the FDA informed doctors of additions to the Avandia warning label which pointed out the possibility of excess fluid retention and congestive heart failure. Later in 2002 the FDA again request a change in the Avandia warning material to reflect reports of unusual weight increases associated with use of the drug. Three changes to the Avandia warning label were requested by the FDA in 2007 all of which indicated the risk of heart problems resulting from use of the drug, including myocardial ischemia and heart failure. Other dangerous Avandia side effects include: * Stroke * Liver toxicity * Primary pulmonary hypertension * Increased cholesterol levels Case Detail: # This Alert Affects: Non smoking individuals with Type 2 Diabetes who were prescribed Avandia and suffered serious health complications, such as heart attack, stroke, or heart failure, may be eligible to participate in Avandia litigation. Family members of individuals who have died because of Avandia side effects may also be eligible to recover compensation for their loss. # Damages: Avandia has been linked to congestive heart failure, heart damage, heart attack, hemorrhagic stroke, ischemic stroke, macular edema, and sudden cardiac death. Bone fractures have also been reported in females. # Company(ies): GlaxoSmithKline # Additional Details: Avandia was introduced in 1999 and was designed to be a safer alternative to drugs that were previously available. It is prescribed to diabetes patients as part of a treatment program for type 2 diabetics that includes diet restrictions and a regular exercise. # Date: This product has not been recalled, but the FDA issued a safety warning for Avandia in May 2007. |
|
|
|
|